Insider · CIK 0001835674
Josette Sheeran
Files at GOEV (Canoo Inc.), CYAB (CYABRA, INC.). First filing Nov 22, 2023, latest Nov 22, 2023.
In brief
Josette Sheeran files SEC Form 4 as director and president at GOEV (Canoo Inc.), and also at CYAB (CYABRA, INC.). Since Nov 22, 2023, Josette Sheeran has reported 0 open-market buys worth $0 and 1 open-market sell worth $7,195, the latest filed on Nov 22, 2023.
A track record needs three past buys with six months of prices behind them; Josette Sheeran has 0, so none is measured yet.
The newest scored trade: sold $7,195 of GOEV on Nov 20, 2023, filed Nov 22, 2023, scored 28 (weak).
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | CYAB CYABRA, INC. | AGrant or award Stock Option (Right to Buy)derivative | +144,387 | - | - | 144,387 | Mar 31, 2026 |
| Nov 20, 2023 | GOEV Canoo Inc. | SOpen-market sale Common Stock | -22,484 | $0.32 | $7,195 | 1,313,975 | Nov 22, 2023 |
Questions about Josette Sheeran
Answered from the filings on this page, as of the latest one.
Is Josette Sheeran buying or selling?
Not in the last 12 months. Josette Sheeran's latest open-market trade on SEC Form 4 was sold $7,195 of GOEV on Nov 20, 2023.
How did Josette Sheeran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Josette Sheeran has 0.
Where does Josette Sheeran file Form 4?
Josette Sheeran has filed Form 4 at GOEV (Canoo Inc.) as President; CYAB (CYABRA, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.